Effects of vitamin A supplementation on therapeutic outcomes in obese women undergoing in vitro fertilizatio
Phase 1
Not yet recruiting
- Conditions
- Obesity
- Registration Number
- ITMCTR1900002677
- Lead Sponsor
- The Affiliated Hospital of Shandong University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
Infertile women with BMI >= 30kg/m2 who received IVF or ICSI treatment.
Exclusion Criteria
If there are the following conditions, then excluded: aged >= 40 years, male and female karyotype abnormalities, severe endometriosis, hydrosallopian tube, congenital or acquired uterine dysplasia and other assisted reproductive technology contraindications.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie vitamin A's impact on IVF outcomes in obese women?
How does vitamin A supplementation compare to standard-of-care in improving IVF success rates for obese patients?
Are there specific biomarkers that correlate with improved fertility outcomes in obese women following vitamin A treatment?
What are the potential adverse effects of vitamin A supplementation during IVF in obese individuals and how can they be managed?
What combination therapies involving vitamin A are being explored for enhancing reproductive outcomes in obesity-related infertility?